U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: Proper Labeling of Honey and Honey Products
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: Proper Labeling of Honey and Honey Products March 2018

Final
Docket Number:
FDA-2006-P-0207
Issued by:
Guidance Issuing Office
Human Foods Program

This guidance is intended to advise the regulated industry on the proper labeling of honey and honey products in accordance with sections 402 and 403 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 342 and 343) and its implementing regulations.

Accurate and consistent labeling of honey and honey products helps to ensure that honey and honey products are not adulterated or misbranded and enhances consumers’ ability to make informed choices among products.

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities.

Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in FDA guidances means that something is suggested or recommended, but not required.

Throughout this guidance, “you” refers to firms that manufacture, process, pack, label, or distribute honey and honey products and to persons who are authorized to act on behalf of such firms.  

Download the Guidance


Related Information


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2006-P-0207.

Back to Top